Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03BB Anticholinergics
R03BB07 Umeclidinium bromide
D10181 Umeclidinium bromide (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilators, Anticholinergic
Umeclidinium
D10181 Umeclidinium bromide (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
225 Bronchodilators
2259 Others
D10181 Umeclidinium bromide (JAN/USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01253 Umeclidinium
D10181 Umeclidinium bromide
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG01253 Umeclidinium
D10181 Umeclidinium bromide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D10181 Umeclidinium bromide (JAN/USAN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10181
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10181
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10181
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01253 Umeclidinium
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG01253 Umeclidinium